NCAM1 and plasma cell myeloma: CyIgκ and cyIgλ are extremely important to confirm the clonality of myeloma cells, and thus, ruling out the polyclonal cells, which express aberrant antigens such as CD56 and CD200, is impossible without anti-cyIgκ and anti-cyIgλ antibodies.